News

RPJ’s Nafasika Karavida Featured In Success.com Article on WordPress and WP Engine

In a recent article for Success.com, RPJ’s Nafsika Karavida explores the escalating trademark dispute between WordPress founder Matt Mullenweg and hosting provider WP Engine. She provides valuable insight into the legal complexities of the case and the potential impact on businesses that depend on the open-source CMS. The article describes...

Read More

RPJ’s Nafsika Karavida Featured on Panel Navigating International Business Employment, Immigration and Transatlantic Mobility before Members of the European American Chamber of Commerce

Yesterday, Nafsika Karavida of RPJ, along with Naveen Bhora of WR Immigration, addressed European American Chamber of Commerce Members on legal issues in international business and employment in their panel presentation: “Immigration and Employment Issues – How European and US Citizens Navigate Living & Working Across the Pond.” Ms. Karavida...

Read More

RPJ’s Nafsika Karavida Featured in HR.com Article: Remote Work: Navigating U.S. Employment Laws While Living Abroad

The global COVID-19 pandemic has fundamentally transformed how many of us live our lives. One of the most notable developments, perhaps, is how the outbreak has radically transformed the nature of our U.S. workforce. An “office” could now be a local coffeeshop, a public library, or even one’s bedroom. Thanks...

Read More

Big News for News Publishers: A New Efficient Framework for Registering News Websites

Last month, the U.S. Copyright Office (the “Copyright Office”) proposed new rules that would make it easier to obtain copyright registration for frequently updated news websites.  The Copyright Office invites comments on the proposal which must be in writing and received by the Copyright Office by February 20, 2024.[1] Background...

Read More

How the Supreme Court’s Decision in Amgen v. Sanofi Impacts Pharmaceutical Patents

By: Nafsika Karavida On May 18, 2023, the Supreme Court of the United States (the “Court” or “SCOTUS”) handed down its decision in Amgen Inc. v. Sanofi (“Amgen/Sanofi” or the “Amgen case”) [1] , a fairly notorious case among pharmaceutical companies and patent nerds.  Amgen/Sanofi is about the so-called enablement...

Read More

The Latest from the White House – An Executive Order in Support of Increased Domestic Production of Federally Funded Inventions

By: Nafsika Karavida On July 28, 2023, President Biden signed Executive Order “Federal Research and Development in Support of Domestic Manufacturing and United States Jobs,” also known as “Invent it Here, Make it Here.”[1] The main purpose of the Executive Order (“EO”) is to boost domestic manufacturing of inventions that...

Read More